scholarly journals About Lung Cancer in Romania and Constanta County

2020 ◽  
Vol 26 (3) ◽  
pp. 145-149
Author(s):  
Severin Beatrice ◽  
Broasca Madar Valentin ◽  
Mocanu Elena ◽  
Ionita Oana ◽  
Chirila Sergiu
Keyword(s):  
Breast Cancer ◽  
Lung Cancer ◽  
Cause Of Death ◽  
Patients With Cancer ◽  
Common Cancer ◽  
Incidence Of Cancer

Abstract Abstract: In Romania lung cancer represents the second most common cancer after breast cancer, for both sexes, and is the leading cause of death among patients with cancer. Between 2011 and 2019 the incidence of cancer had a growing trend for both Romania and Constanta County. Unfortunately, the forecast regarding the incidence of cancer in Romania shows a trend of continuous rise of new cancer cases until 332.7%000 inhabitants by 2025. In these conditions we wanted to analyze some aspects of lung cancer situation in Constanta County.

Cancer as a Scottish Problem

1968 ◽  
Vol 13 (10) ◽  
pp. 338-348
Author(s):  
A. J. Haddow
Keyword(s):  
Breast Cancer ◽  
Lung Cancer ◽  
Cause Of Death ◽  
Cancer Mortality ◽  
Time Lag ◽  
Age Distribution ◽  
Lung Cancer Mortality ◽  
Cervix Uteri ◽  
Hospital Treatment ◽  
Cancer Of The Lung

Cancer, responsible for about 1 death in 5 in Scotland, cost over £1 per head of population in 1965 and led to bed occupation of almost 2,000 bed years. Time lag (symptoms-doctor-hospital-treatment) is usuallv small. Age distribution is as in other European countries. Excluding accidents, cancer is the second most important cause of death in children. In relation to other countries Scotland's position is very poor and the lung cancer mortality in both sexes is the highest known. Lung cancer is the most important in males, breast cancer in females. Alimentary cancers come second in both sexes. In this century alimentary cancers increased till the thirties or forties and then declined. Cancers of pancreas, cervix uteri, ovary, prostate, kidney and bladder, together with leukaemia, have all increased. Cancer of the lung has increased elevenfold in women and fiftyfold in men. It now accounts for 9 to 12 per cent of all male deaths in cities and large towns

Projection of cancer incidence and death to 2040 in the US: Impact of cancer screening and a changing demographic.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. 1566-1566 ◽  
Author(s):  
Lola Rahib ◽  
Mackenzie Wehner ◽  
Lynn McCormick Matrisian ◽  
Kevin Thomas Nead
Keyword(s):  
Breast Cancer ◽  
Colorectal Cancer ◽  
Lung Cancer ◽  
Cancer Screening ◽  
Cancer Incidence ◽  
Intrahepatic Bile Duct ◽  
Death Rates ◽  
Screening Programs ◽  
Common Cancer ◽  
The Us

1566 Background: Coping with the current and future burden of cancer requires an in-depth understanding of cancer incidence and death trends. As of 2020, breast, lung, prostate, and colorectal cancer are the most incident cancers, while lung, colorectal, pancreas, and breast cancer result in the most deaths. Here we integrate observed cancer statistics and trends with observed and estimated US demographic data to project cancer incidences and deaths to the year 2040. Methods: Demographic cancer-specific delay-adjusted incidence and death rates from the Surveillance, Epidemiology, and End Results Program (2014-2016) were combined with US Census Bureau population growth projections (2016) and average annual percentage changes in incidence (2011-2015) and death (2012-2016) rates to project cancer incidences and deaths through the year 2040. We examined the 10 most incident and deadly cancers as of 2020. We utilized Joinpoint analysis to examine changes in incidence and death rates over time relative to changes in screening guidelines. Results: We predict the most incident cancers in 2040 in the US will be breast (322,000 diagnoses in 2040) and lung (182,000 diagnoses in 2040) cancer. Continuing decades long observed incident rate trends we predict that melanoma (173,000 diagnoses in 2040) will become the 3rd most common cancer while prostate cancer (63,000 diagnoses in 2040) will become the 5th most common cancer after colorectal cancer (139,000 diagnoses in 2040). Lung cancer (61,000 deaths in 2040) is predicted to continue to be the leading cause of cancer related death, with pancreas (45,000 deaths in 2040) and liver & intrahepatic bile duct (38,000 deaths in 2040) cancer surpassing colorectal cancer (34,000 deaths in 2040) to become the second and third most common causes of cancer related death, respectively. Breast cancer deaths (29,000 in 2040) are predicted to continue to decrease and become the fifth most common cause of cancer death. Joinpoint analysis of incidence and death rates supports a significant past, present, and future impact of cancer screening programs on the number of cancer diagnoses and deaths, particularly for prostate, thyroid, melanoma incidences, and lung cancer deaths. Conclusions: We demonstrate marked changes in the predicted landscape of cancer incidence and deaths by 2040. Our analysis reveals an influence of cancer screening programs on the number of cancer diagnoses and deaths in future years. These projections are important to guide future research funding allocations, healthcare planning, and health policy efforts.

scholarly journals Characteristics of Chest X-Ray in Patients with Cancer at the Dharmais Cancer Hospital Emergency Room during the COVID-19 Pandemic

2021 ◽  
Vol 15 (4) ◽  
pp. 195
Author(s):  
Bima Taruna Sakti ◽  
Rosalina Rosalina ◽  
Jaka Pradipta
Keyword(s):  
Breast Cancer ◽  
Lung Cancer ◽  
Pleural Effusion ◽  
Pleural Effusions ◽  
Hospital Emergency ◽  
X Ray ◽  
Patients With Cancer ◽  
Cancer Hospital ◽  
Hospital Emergency Room ◽  
Chest X Ray

Background: Conventional chest X-ray (chest X-ray) in Dharmais Cancer Hospital emergency room (ER) is still the primary modality to diagnose patients with cancer with dyspnoea complaints. Chest X-ray was also carried out to screen inpatients at the Dharmais Cancer Hospital ER at the beginning of the COVID-19 pandemic in Indonesia. It was essential because patients in the Dharmais Cancer Hospital ER were patients with cancer, with low immunity and a high risk of being exposed to various infections. Thus, the purpose of this study was to determine the characteristics of chest X-rays in patients with cancer at the Dharmais Cancer Hospital ER during the COVID-19 pandemic in February-May 2020. Methods: This was a descriptive study. The population involved was all patients at the Dharmais Cancer Hospital ER who received chest X-ray support, with the inclusion criteria for diagnosing lung cancer, breast cancer, cervical cancer, colorectal cancer, and blood cancer (Leukemia) from February to May 2020. Data analysis employed univariate analysis by utilizing tables and graphs in presenting the data.Results: 289 samples met the research criteria. The highest visits were patients with breast cancer (41.2%). The most common thoracic images were pleural effusion (34.3%), followed by bronchopneumonia (31.1%), normal lung (16.6%), lung mass (7.6%), pneumonia (5.2%), and others (5.2%), consisting of atelectasis, bronchitis, fibrosis/chronic pulmonary process, pulmonary emphysema, cardiomegaly, and specific process. Besides, the chest x-ray bronchopneumonia was 31.1% (90 samples), accompanied by pleural effusion of 44.4%. From the chest X-ray, pleural effusions were 34.3% (99 samples), with lung cancer being the most common with pleural effusions (48.4%).Conclusions: More than 80% of chest x-ray performed in the ER are abnormal. Also, breast cancer is the highest in the Dharmais Cancer Hospital ER cases, with the highest chest x-ray of pleural effusion.

scholarly journals The Effectiveness of Cognitive Behavioral Therapy (CBT) To Decreased Depression in Woman Patients with Cancer included cervical cancer and breast cancer

2019 ◽  
Vol 6 (3) ◽  
pp. 27
Author(s):  
Dwi Fitriyanti ◽  
Mardiyono Mardiyono ◽  
Yuriz Bakhtiar
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Cervical Cancer ◽  
Cognitive Behavioral Therapy ◽  
Cause Of Death ◽  
Behavioral Therapy ◽  
Cognitive Behavioral ◽  
Future Research ◽  
Newly Diagnosed ◽  
Patients With Cancer

<em>The highest cancers in Indonesia in women are breast cancer and cervical cancer. Both are the most common cancers in women and the highest cause of death in women. Some woman patients with newly diagnosed of breast cancer or cervical cancer will experience depression. most patients newly diagnosed with cancer, less than 6 months reported a feeling of depression of 91.4%. An effective intervention to reduce the level of depression is to provide cognitive behavioral therapy (CBT) interventions. CBT is a psychotherapy recommended for treating depression in patients with breast cancer and cervical cancer. The objective of this study to review the effects of CBT on decreasing depression in woman patients with cancer including cervical cancer and breast cancer. This study is a systematic review. We search articles from EBSCOhost, Google Scholar, Pubmed, and Science Direct database which published from 2008 till 2018. RCTs are included in this review. Four RCTs included in this study. CBT interventions are carried out differently for each article, in general, each session is given for 60-90 minutes with a different number of sessions. Outcome measured in 3 articles was more than one variable (not only depression) and one article only measured the level of depression. Cognitive behavioral therapy can be used for woman patients with breast cancer and cervical cancer who are depressed. Future research to the effectiveness of CBT in reducing depression in woman patients specifically in newly diagnosed with cervical cancer is needed to confirm the evidence</em>

Serum Folate Binding Capacity in Patients with Solid Tumors

1981 ◽  
Vol 67 (2) ◽  
pp. 101-104 ◽  
Author(s):  
Roberto Corrocher ◽  
Maria Luisa Pachor ◽  
Lisa Maria Bambara ◽  
Anna Maria Stanziai ◽  
Domenico Biasi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lung Cancer ◽  
Solid Tumors ◽  
Binding Capacity ◽  
The Other ◽  
Serum Folate ◽  
Cancer Tissue ◽  
Gi Tract ◽  
Patients With Cancer ◽  
Cancer Of The Stomach

Total and unsaturated folate binding capacity (TFBC-UFBC) was measured in 44 normal volunteers and in 77 patients with solid tumors; of them 31 had a lung cancer, 18 a cancer of the gastrointestinal tract (GI), and 28 a breast cancer. With the exception of patients with cancer of the stomach, all the other groups showed a significant increase in TFBC. An increase in UFBC was statistically observed in patients with lung cancer and cancer of the GI tract. No correlation was observed in breast cancer between the presence of hormon receptors on cancer tissue and the value of TFBC. However, a significant increase in TFBC was noted in this group of patients when metastases were present.

scholarly journals Breast Cancer Diagnosis Using K-means ‎Methodology

2017 ◽  
Vol 26 (1) ◽  
pp. 9-16
Author(s):  
Noor Kadhim Ayoob
Keyword(s):  
Breast Cancer ◽  
Lung Cancer ◽  
Cause Of Death ◽  
Cancer Diagnosis ◽  
Computer Systems ◽  
Breast Cancer Diagnosis ◽  
Medical Personnel ◽  
Global Database ◽  
Disease Research ◽  
Cancer Breast

After lung cancer, breast cancer is the second cause of death among women. Due to the seriousness of the disease, research has stepped up to help diagnose this disease by providing medical personnel with a classification based computer systems that determine whether the patient is infected. This research focuses on the use method (K-means) for the diagnosis of breast cancer based on a global database known as (WBCD) dedicated to this purpose. The proposed method has proved its effectiveness in classification and the accuracy of the system is equal to 96.4861%.

Perbandingan CART dan Random Forest untuk Deteksi Kanker berbasis Klasifikasi Data Microarray

2020 ◽  
Vol 4 (5) ◽  
pp. 805-812
Author(s):  
Riska Chairunisa ◽  
Adiwijaya ◽  
Widi Astuti
Keyword(s):  
Breast Cancer ◽  
Lung Cancer ◽  
Ovarian Cancer ◽  
Random Forest ◽  
Classification And Regression Tree ◽  
Classification Method ◽  
Discrete Wavelet ◽  
Prostate Tumors ◽  
Cancer Data ◽  
Colon Tumors

Cancer is one of the deadliest diseases in the world with a mortality rate of 57,3% in 2018 in Asia. Therefore, early diagnosis is needed to avoid an increase in mortality caused by cancer. As machine learning develops, cancer gene data can be processed using microarrays for early detection of cancer outbreaks. But the problem that microarray has is the number of attributes that are so numerous that it is necessary to do dimensional reduction. To overcome these problems, this study used dimensions reduction Discrete Wavelet Transform (DWT) with Classification and Regression Tree (CART) and Random Forest (RF) as classification method. The purpose of using these two classification methods is to find out which classification method produces the best performance when combined with the DWT dimension reduction. This research use five microarray data, namely Colon Tumors, Breast Cancer, Lung Cancer, Prostate Tumors and Ovarian Cancer from Kent-Ridge Biomedical Dataset. The best accuracy obtained in this study for breast cancer data were 76,92% with CART-DWT, Colon Tumors 90,1% with RF-DWT, lung cancer 100% with RF-DWT, prostate tumors 95,49% with RF-DWT, and ovarian cancer 100% with RF-DWT. From these results it can be concluded that RF-DWT is better than CART-DWT.  

THE PREVALENCE OF HEPATITIS B REACTIVATION (HBV) IN CANCER PATIENTS TREATING WITH CHEMOTHERAPY

2016 ◽  
pp. 74-80
Author(s):  
Phuong Phung ◽  
Thi Thuy Nguyen
Keyword(s):  
Breast Cancer ◽  
Lung Cancer ◽  
Hepatitis B ◽  
Cancer Patients ◽  
Positive Control ◽  
High Dose ◽  
Hbv Reactivation ◽  
Endemic Region ◽  
Hepatitis B Reactivation ◽  
Cancer Breast

ackground and Objectives: Nowadays, the incidence of cancer is constantly increasing in the world as well as in Vietnam. The treatment of cancer is based on multimodality principle. Among those principal modalities, chemotherapy is widely used for different purposes such as neoadjuvant, andjuvant and palliation. However, chemotherapy can induce activation of latent infections, including hepatitis B. Vietnam is in the endemic region of hepatitis B so the reactivation of hepatitis B on cancer patients with chemotherapy has emerged a concerned problem. However, few interests were gained on this problem in the aspect of clinical setting or researching. Aims: to determine the prevalence of hepatitis B reactivation (HBV) in cancer patients treating with chemotherapy and to detect some risks factors of this situation. Subjects and methods: descriptive prospective. The study included 33 cancer patients with inactive HBV infection who are treating with chemotherapy. We define HBV reactivation by ALT > 3 ULN and HBV DNA copies > 10 positive control limit. Results: We found 6 patients with reactivated HBV, accounting for 18.18 %. Among reactivated HBV patients, age less than 60 accounts 83,33%. Rate of reactivated HBV in males was 25,00% while this rate in females was 14,28%. Rate of reactivated HBV in lymphoma, lung cancer and breast cancer was 33,33%, 25% và 22,22% respectively. Clinial manifestation of reactivated HBV includes jaundice (33,33%), fulminant hepatic failure (6%) and death (5%). The reactivated rate was higher in patients got high dose of corticoid (28,57%) vs low dose (15,38%). This rate was 29,41% in patients treated with anthracyclines which was higher than in group without anthracyclines. The reactivated rate of HBV was dramatically higher in patients treated with rituximab (75%). Conclusion: the reactivation of hepatitis B on cancer patients with chemotherapy is common. We found 6 patients with reactivated HBV of 33 subjects of the study which accounts 18.18 %. We recognized that reactivated HBV rate was higher subgroups of age < 60 years old, males, patients with lymphoma, lung cancer, breast cancer. Reactivated HBV may be more prevalent in patients with high-dose corticotherapy, anthracyclines and Rituximab. Key words: HBV reactivation, chemotherapy, cancer, hepatitis B

Sign in / Sign up

Export Citation Format

Share Document